Citadel Advisors’s Immuron IMRN Stock Holding History

Citadel Advisors’s Portfolio IMRN Stock Details IMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.7K	Buy	43,123 +29,319	+212%	+$29.2K	﹤0.01%	13163
2026 Q1	$10.7K	Sell	13,804 -31,978	-70%	-$26.6K	﹤0.01%	12749
2025 Q4	$34.9K	Buy	45,782 +26,220	+134%	+$43.2K	﹤0.01%	12169
2025 Q3	$37.4K	Buy	+19,562	New	+$35K	﹤0.01%	12321
2023 Q2	–	Sell	-31,252	Closed	-$57.5K	–	14765
2023 Q1	$57.5K	Sell	31,252 -15,325	-33%	-$30.9K	﹤0.01%	11979
2022 Q4	$96.9K	Buy	+46,577	New	+$93.1K	﹤0.01%	11264

Other funds holding IMRN

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's IMRN Position: Q2 2026 in Review

Citadel Advisors increased its Immuron (IMRN) stake by 212% in Q2 2026, buying an estimated $29.2K and bringing the position to 43,123 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #13163.

Citadel Advisors first reported a position in IMRN in Q4 2022 and has held it in 6 quarters since. The position peaked at $96.9K in Q4 2022. 6 funds tracked by Wall St. Rank hold IMRN as of Q2 2026.

Citadel Advisors held 43,123 shares of Immuron worth $45.7K as of Q2 2026.
Citadel Advisors bought 29,319 Immuron shares in Q2 2026, an estimated $29.2K.
Immuron made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13163 holding.
Citadel Advisors first reported a position in Immuron in Q4 2022 and has held it in 6 quarters since.
Citadel Advisors's Immuron position peaked at $96.9K in Q4 2022.
6 funds tracked by Wall St. Rank held Immuron as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.